Mulder Bart A, Damman Kevin, Van Veldhuisen Dirk J, Van Gelder Isabelle C, Rienstra Michiel
Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
Clin Cardiol. 2017 Sep;40(9):740-745. doi: 10.1002/clc.22725. Epub 2017 May 17.
Heart rate has been associated with prognosis in patients with heart failure with reduced ejection fraction (HFREF) and sinus rhythm; whether this also holds true in patients with atrial fibrillation (AF) is unknown.
To evaluate cardiac rhythm and baseline heart rate and the influence of outcome in patients with HFREF enrolled in the Cardiac Insufficiency Bisoprolol Study II.
In total, 2539 patients were stratified according to their baseline heart rhythm (AF or sinus rhythm) and into quartiles of heart rate (≤70 bpm, 71-78 bpm, 79-90 bpm, and >90 bpm). The primary outcome was all-cause mortality. Mean follow-up was 1.3 years.
Mean age was 61 years, mean left ventricular ejection fraction was 28%, and 80% were male. A total of 521 (21%) patients had AF at baseline. The risk associated with all-cause mortality for each 5 bpm increase in heart rate in patients with sinus rhythm (hazard ratio [HR]: 1.06, 95% confidence interval [CI]: 1.01-1.11, P = 0.012) was significantly different from those with AF (HR: 1.00, 95% CI: 0.94-1.07, P = 0.90, P for interaction = 0.041). The risk associated with higher heart rate in sinus rhythm was primarily attributable to excess risk in the highest quartile (HR: 1.64, 95% CI: 1.18-2.30, P = 0.003). Allocation to bisoprolol did not modify the interaction between heart rate, rhythm and outcome.
In HFREF patients with AF, a higher heart rate is not associated with increased event rates in contrast to HFREF patients with sinus rhythm.
心率与射血分数降低的心力衰竭(HFREF)且为窦性心律患者的预后相关;而这在心房颤动(AF)患者中是否同样成立尚不清楚。
评估心脏节律、基线心率以及心脏再同步化治疗-心力衰竭研究II(Cardiac Insufficiency Bisoprolol Study II)中纳入的HFREF患者的结局影响因素。
总共2539例患者根据其基线心律(AF或窦性心律)以及心率四分位数(≤70次/分钟、71 - 78次/分钟、79 - 90次/分钟和>90次/分钟)进行分层。主要结局为全因死亡率。平均随访时间为1.3年。
平均年龄为61岁,平均左心室射血分数为28%,80%为男性。共有521例(21%)患者基线时患有AF。窦性心律患者心率每增加5次/分钟,全因死亡风险(风险比[HR]:1.06,95%置信区间[CI]:1.01 - 1.11,P = 0.012)与AF患者(HR:1.00,95% CI:0.94 - 1.07,P = 0.90,交互作用P = 0.041)显著不同。窦性心律中较高心率相关风险主要归因于最高四分位数中的额外风险(HR:1.64,95% CI:1.18 - 2.30,P = 0.003)。分配至比索洛尔未改变心率、心律与结局之间的交互作用。
与窦性心律的HFREF患者相比,AF的HFREF患者中心率较高与事件发生率增加无关。